ArticleCancer diagnosis & prognosis

Results of a Phase II Trial Testing the Resensitization With Trabectedin in Platinum-resistant Ovarian Cancer.

Gloria Marquina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.